OBJECTIVE: Mesenteric fat, a reflection of visceral adiposity, may play an important role in the pathogenesis of metabolic syndrome and cardiovascular diseases (CVD). In this study, we examined the independent relationship between mesenteric fat thickness and metabolic syndrome and defined its optimal cutoff value to identify high-risk subjects for metabolic syndrome and CVD. RESEARCH DESIGN AND METHODS: A total of 290 Chinese subjects had an ultrasound examination for measurements of thickness of mesenteric, preperitoneal, and subcutaneous fat as well as carotid intima-media thickness (IMT). Anthropometric measurements and metabolic risk profile were assessed by physical examination and blood taking. RESULTS: Twenty (6.9%) subjects had metabolic syndrome according to the National Cholesterol Education Panel Adult Treatment Panel III criteria with Asian definitions for central obesity (waist circumference >80 cm in women and >90 cm in men). Mesenteric fat thickness had significant correlations (P < 0.05) with various metabolic variables. On multivariate regression, mesenteric fat thickness was an independent determinant of all components of metabolic syndrome after adjustment for age, sex, homeostasis model assessment of insulin resistance, and other fat deposits. The odds ratio of metabolic syndrome was increased by 1.35 (95% CI 1.10-1.66)-fold for every 1-mm increase in mesenteric fat thickness. On receiver-operating characteristic curve analysis, mesenteric fat thickness of > or =10 mm was the optimal cutoff value to identify metabolic syndrome, with sensitivity of 70% and specificity of 75%. Subjects with mesenteric fat thickness > or =10 mm had higher carotid IMT than those with thickness <10 mm (0.73 +/- 0.19 vs. 0.64 +/- 0.16 mm, P = 0.001). CONCLUSIONS: Mesenteric fat thickness was an independent determinant of metabolic syndrome and identified subjects with increased carotid IMT.
OBJECTIVE: Mesenteric fat, a reflection of visceral adiposity, may play an important role in the pathogenesis of metabolic syndrome and cardiovascular diseases (CVD). In this study, we examined the independent relationship between mesenteric fat thickness and metabolic syndrome and defined its optimal cutoff value to identify high-risk subjects for metabolic syndrome and CVD. RESEARCH DESIGN AND METHODS: A total of 290 Chinese subjects had an ultrasound examination for measurements of thickness of mesenteric, preperitoneal, and subcutaneous fat as well as carotid intima-media thickness (IMT). Anthropometric measurements and metabolic risk profile were assessed by physical examination and blood taking. RESULTS: Twenty (6.9%) subjects had metabolic syndrome according to the National Cholesterol Education Panel Adult Treatment Panel III criteria with Asian definitions for central obesity (waist circumference >80 cm in women and >90 cm in men). Mesenteric fat thickness had significant correlations (P < 0.05) with various metabolic variables. On multivariate regression, mesenteric fat thickness was an independent determinant of all components of metabolic syndrome after adjustment for age, sex, homeostasis model assessment of insulin resistance, and other fat deposits. The odds ratio of metabolic syndrome was increased by 1.35 (95% CI 1.10-1.66)-fold for every 1-mm increase in mesenteric fat thickness. On receiver-operating characteristic curve analysis, mesenteric fat thickness of > or =10 mm was the optimal cutoff value to identify metabolic syndrome, with sensitivity of 70% and specificity of 75%. Subjects with mesenteric fat thickness > or =10 mm had higher carotid IMT than those with thickness <10 mm (0.73 +/- 0.19 vs. 0.64 +/- 0.16 mm, P = 0.001). CONCLUSIONS: Mesenteric fat thickness was an independent determinant of metabolic syndrome and identified subjects with increased carotid IMT.
Authors: Leah C Solberg Woods; Brett C Woods; Caroline M Leitschuh; Sonia J Laurie; Howard J Jacob Journal: J Nutrigenet Nutrigenomics Date: 2012-06-19
Authors: S Vogelezang; O Gishti; J F Felix; E M van der Beek; M Abrahamse-Berkeveld; A Hofman; R Gaillard; V W V Jaddoe Journal: Int J Obes (Lond) Date: 2015-12-21 Impact factor: 5.095
Authors: Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland Journal: Cell Metab Date: 2013-04-11 Impact factor: 27.287
Authors: Claudia H T Tam; Ronald C W Ma; Wing Yee So; Ying Wang; Vincent K L Lam; Soren Germer; Mitchell Martin; Juliana C N Chan; Maggie C Y Ng Journal: Diabetes Date: 2008-12-10 Impact factor: 9.461
Authors: Linda C Enns; John F Morton; Ruby Sue Mangalindan; G Stanley McKnight; Michael W Schwartz; Matt R Kaeberlein; Brian K Kennedy; Peter S Rabinovitch; Warren C Ladiges Journal: J Gerontol A Biol Sci Med Sci Date: 2009-09-23 Impact factor: 6.053
Authors: Susanne Holzhauer; Renate M L Zwijsen; Vincent W V Jaddoe; Guenther Boehm; Henriette A Moll; Paul G Mulder; Veronica A Kleyburg-Linkers; Albert Hofman; Jacqueline C M Witteman Journal: Eur J Epidemiol Date: 2009-07-29 Impact factor: 8.082